Publications by authors named "Matthew Coffey"

Claim this Profile
A
A Phase II Randomized Study of Paclitaxel Alone or Combined with Pelareorep with or without Avelumab in Metastatic Hormone Receptor-Positive Breast Cancer: The BRACELET-01/PrE0113 Study.
Amy S Clark, Fengmin Zhao, Paula Klein, Alberto J Montero, Carla Falkson, Matthew C Coffey

Clin Cancer Res· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The spatial distribution of a hummingbird-pollinated plant is not strongly influenced by hummingbird abundance.
Matthew L Coffey, Andrew M Simons

Am J Bot· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Latitudinal trends in mating system traits in the highly self-fertilizing revealed by community science.
Matthew L Coffey, Andrew M Simons

Ecol Evol· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Elucidation of Pelareorep Pharmacodynamics in A Phase I Trial in Patients with -Mutated Colorectal Cancer.
Sanjay Goel, Allyson J Ocean, Ruwan Y Parakrama, Mohammad H Ghalib, Imran Chaudhary, Matthew Coffey

Mol Cancer Ther· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antibody-Neutralized Reovirus Is Effective in Oncolytic Virotherapy.
Robert A Berkeley, Lynette P Steele, Aat A Mulder, Diana J M van den Wollenberg, Timothy J Kottke, Matthew Coffey

Cancer Immunol Res· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase II Study of Pelareorep (REOLYSIN) in Combination with Gemcitabine for Patients with Advanced Pancreatic Adenocarcinoma.
Devalingam Mahalingam, Sanjay Goel, Santiago Aparo, Sukeshi Patel Arora, Nicole Noronha, Matthew Coffey

Cancers (Basel)· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oncolytic reovirus as a combined antiviral and anti-tumour agent for the treatment of liver cancer.
Adel Samson, Matthew J Bentham, Karen Scott, Gerard Nuovo, Abigail Bloy, Matthew Coffey

Gut· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intravenous delivery of oncolytic reovirus to brain tumor patients immunologically primes for subsequent checkpoint blockade.
Adel Samson, Karen J Scott, David Taggart, Emma J West, Erica Wilson, Matthew C Coffey

Sci Transl Med· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Toll like receptor 3 as an immunotherapeutic target for KRAS mutated colorectal cancer.
Radhashree Maitra, Titto Augustine, Yitzchak Dayan, Carol Chandy, Matthew Coffey

Oncotarget· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase II study of REOLYSIN (pelareorep) in combination with carboplatin and paclitaxel for patients with advanced malignant melanoma.
Devalingam Mahalingam, Christos Fountzilas, Jennifer Moseley, Nicole Noronha, Hue Tran, Matthew Coffey

Cancer Chemother Pharmacol· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oncolytic reovirus in combination with chemotherapy in metastatic or recurrent non-small cell lung cancer patients with KRAS-activated tumors.
Miguel A Villalona-Calero, Elaine Lam, Gregory A Otterson, Weiqiang Zhao, Matthew Timmons, Matthew Coffey

Cancer· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oncolytic reovirus preferentially induces apoptosis in KRAS mutant colorectal cancer cells, and synergizes with irinotecan.
Radhashree Maitra, Raviraja Seetharam, Lydia Tesfa, Titto A Augustine, Lidija Klampfer, Matthew C Coffey

Oncotarget· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reovirus-associated reduction of microRNA-let-7d is related to the increased apoptotic death of cancer cells in clinical samples.
Gerard J Nuovo, Michela Garofalo, Nicola Valeri, Vicki Roulstone, Stefano Volinia, Matthew C Coffey

Mod Pathol· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Internalization of oncolytic reovirus by human dendritic cell carriers protects the virus from neutralization.
Elizabeth J Ilett, Montserrat Bárcena, Fiona Errington-Mais, Stephen Griffin, Kevin J Harrington, Matthew Coffey

Clin Cancer Res· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intravenous administration of Reolysin, a live replication competent RNA virus is safe in patients with advanced solid tumors.
Radharani Gollamudi, Mohammad H Ghalib, Kavita K Desai, Imran Chaudhary, Benny Wong, Matthew Coffey

Invest New Drugs· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reovirus-based therapy for cancer.
Kevin Kelly, Steffan Nawrocki, Alain Mita, Matthew Coffey, Francis J Giles

Expert Opin Biol Ther· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synergistic antitumor activity of oncolytic reovirus and chemotherapeutic agents in non-small cell lung cancer cells.
Shizuko Sei, Jodie K Mussio, Quan-en Yang, Kunio Nagashima, Ralph E Parchment, Matthew C Coffey

Mol Cancer· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systemic reovirus therapy of metastatic cancer in immune-competent mice.
Kensuke Hirasawa, Sandra G Nishikawa, Kara L Norman, Matthew C Coffey, Bradley G Thompson

Cancer Res· January 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reovirus oncolysis of human breast cancer.
Kara L Norman, Matthew C Coffey, Kensuke Hirasawa, Douglas J Demetrick, Sandra G Nishikawa

Hum Gene Ther· March 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis